These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32274747)

  • 1. Survival of Patients with First and Metachronous Second Primary Breast Cancer or Lung Cancer Malignancy: Comparisons Using the SEER Database.
    Zhong M; He X; Lei K
    Adv Ther; 2020 May; 37(5):2236-2245. PubMed ID: 32274747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
    Lei K; He X; Yu L; Ni C; Chen H; Guan D; Sun K; Zou H
    PLoS One; 2019; 14(5):e0215948. PubMed ID: 31042767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women.
    Milano MT; Strawderman RL; Venigalla S; Ng K; Travis LB
    J Thorac Oncol; 2014 Aug; 9(8):1081-90. PubMed ID: 25157761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
    Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
    BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin suppression therapy using levothyroxine does not negatively affect breast cancer prognosis.
    He X; Zhong M; Zhang Q; Aierken N; Cui L; Xing Z; Lei K
    Cancer Treat Res Commun; 2022; 31():100525. PubMed ID: 35114502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second cancer, breast cancer, and cardiac mortality in stage T1aN0 breast cancer patients with or without external beam radiation therapy: a national registry study.
    Ye JC; Yan W; Christos P; Nori D; Chao KS; Ravi A
    Clin Breast Cancer; 2015 Feb; 15(1):54-9. PubMed ID: 25223278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation.
    Baumgarten MW; Goemann IM; Scheffel RS; Maia AL
    Clin Breast Cancer; 2024 Aug; 24(6):e519-e527. PubMed ID: 38670860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Survival with Lymphadenectomy in Early-Stage Metachronous Second Primary Lung Cancer: A Retrospective Analysis.
    Zhang J; Lin Y; Zhou J; Geng R; Zheng Z; Guo C; Ma X; Li S
    Oncol Res Treat; 2024; 47(5):198-205. PubMed ID: 38493777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical carcinoid tumor of the lung: a surveillance, epidemiology, and end results database analysis.
    Steuer CE; Behera M; Kim S; Chen Z; Saba NF; Pillai RN; Owonikoko TK; Khuri FR; Ramalingam SS
    J Thorac Oncol; 2015 Mar; 10(3):479-85. PubMed ID: 25371080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study.
    Al-Husseini MJ; Mohamed HH; Saad AM; Gad MM; Atia M; Qaddoora U; Abushouk AI; El-Shinawi M
    Curr Probl Cancer; 2019 Jun; 43(3):213-221. PubMed ID: 30195804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
    Bu X; Wang X; Wei L; Liu J; Chen M
    Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer.
    Ding S; Sun X; Lu S; Wang Z; Chen X; Shen K
    Breast; 2021 Jun; 57():71-79. PubMed ID: 33774461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival analysis of patients with primary breast duct carcinoma and lung adenocarcinoma: a population-based study from SEER.
    Lv F; Cheng M; Jiang L; Zhao X
    Sci Rep; 2021 Jul; 11(1):14790. PubMed ID: 34285322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study.
    Wei JL; Jiang YZ; Shao ZM
    Int J Clin Oncol; 2019 Aug; 24(8):934-940. PubMed ID: 30888527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Second primary cancers after small-cell lung cancer].
    Soria JC; Bréchot JM; Lebeau B; Rochemaure J
    Bull Cancer; 1997 Aug; 84(8):800-6. PubMed ID: 9339185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does muscle invasive bladder cancer following pelvic radiotherapy portend worse prognosis? A seer-based study.
    Natale C; Leinwand G; Zeineddine F; Silberstein JL; Krane LS
    Cancer Treat Res Commun; 2020; 24():100177. PubMed ID: 32454387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer.
    Zhang L; Wu Y; Liu F; Fu L; Tong Z
    Oncotarget; 2016 Aug; 7(32):52450-52459. PubMed ID: 27223440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid Cancer Benefits the Prognosis of Ovarian Cancer: A SEER-Based Study.
    Yang Q; Wu Z; He X; Yu L; Zhang X; Lei K
    Adv Ther; 2019 May; 36(5):1211-1220. PubMed ID: 30879254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
    Malmgren JA; Calip GS; Atwood MK; Mayer M; Kaplan HG
    Cancer; 2020 Jan; 126(2):390-399. PubMed ID: 31639221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric Malignant Phyllodes Tumors of the Breast: Characteristics and Outcomes Based on the Surveillance Epidemiology and End Results Database.
    Xiao Y; Jiang Y; Xiong Y; Ruan S; Huang T
    J Surg Res; 2020 May; 249():205-215. PubMed ID: 31991330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.